Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PADI4 polymorphisms and related haplotype in rheumatoid arthritis patients.

Joint bone spine - 1 Mar 2012

Abd-Allah Somia H, el-Shal Amal S, Shalaby Sally M, Pasha Heba F, Abou el-Saoud Amany M, el-Najjar Amany R, el-Shahawy Eman E

Abstract excerpt

OBJECTIVE: To investigate whether peptidyl arginine deiminase type IV gene (PADI4) polymorphisms contribute to rheumatoid arthritis (RA) susceptibility in Egyptians, whether they influence disease severity and activity, and whether they affect anti-mutated citrullinated vimentin antibodies (anti-MCV) level. METHODS: Three PADI4 single nucleotide polymorphisms (SNPs) (PADI4-92, PADI4-96, and PADI4-102) were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arthritis, Rheumatoid
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Haplotypes

Share to Hydrolases

Share to Protein-Arginine Deiminase Type 4

Share to Protein-Arginine Deiminases

Share to Severity of Illness Index

Source

Identifiers

PMID: 21981985
DOI: 10.1016/j.jbspin.2011.07.006

Genes

PADI4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PADI4 polymorphisms and related haplotype in rheumatoid arthritis patients.PMID 21981985Read ↗

Polymorphisms and functional haplotype in PADI4: further evidence for contribution on rheumatoid arthritis susceptibility and anti-cyclic citrullinated peptide antibodies in a western Mexican population.Semantic proximity Read ↗

Association between PADI4 gene polymorphisms and anti-cyclic citrullinated peptide antibody positive rheumatoid arthritis in a large Chinese Han cohort.Semantic proximity Read ↗

PADI4 Polymorphisms in Iranian Patients with Rheumatoid Arthritis.Semantic proximity Read ↗

A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans.Semantic proximity Read ↗

Molecular Factors in PAD2 (PADI2) and PAD4 (PADI4) Are Associated with Interstitial Lung Disease Susceptibility in Rheumatoid Arthritis Patients.Semantic proximity Read ↗

A functional haplotype of PADI4 gene in rheumatoid arthritis: positive correlation in a French population.Semantic proximity Read ↗

Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study.Semantic proximity Read ↗

Implications of Peptidyl Arginine Deiminase 4 gene transcription and polymorphisms in susceptibility to rheumatoid arthritis in an Iranian population.Semantic proximity Read ↗

PADI4 polymorphisms and the functional haplotype are associated with increased rheumatoid arthritis susceptibility: A replication study in a Southern Mexican population.Semantic proximity Read ↗

Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study.Semantic proximity Read ↗

Polymorphisms in peptidylarginine deiminase associate with rheumatoid arthritis in diverse Asian populations: evidence from MyEIRA study and meta-analysis.Semantic proximity Read ↗

Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.